Medical cannabis and neurology. A very common topic that many studies and scientists are devoted to. Is it possible to combine these two things and make them a common future?
Neurology has been severely limited due to its inability to progress in symptomatic treatment of neurodegenerative diseases. Although cannabis-based drugs should be safe and effective in the treatment of multiple sclerosis (MS), Dravet syndrome and Lennox-Gastaut syndrome, there are still many challenges and trials.
This study analyzes the fascinating discoveries of cannabis-based drugs and their benefits in neurology. These tests included neutral phytocannabinoids including tetrahydrocannabinol (THC), cannabidiol (CBD) and their acid precursors such as tetrahydrocannabinolic acid (THCA) or cannabidiolic acid (CBDA). In addition to the above, we also include terpenoids.
All compounds could find their use in the treatment of five diseases, which are currently marked as incurable and require stronger medical intervention. These include: severe epilepsy, brain tumors, Parkinson's disease (PN), Alzheimer's disease (AD) and traumatic brain injury (TBI) / chronic traumatic encephalopathy (CTE).
Current science and clinical research support the safety and effectiveness of the supplements that can be used to treat these diseases.
Keywords: cannabis, pain, brain tumors, epilepsy, Alzheimer's disease, Parkinson's disease, traumatic brain injury, microbioma
Author of the study: Ethan B. Russo
You can read more of this study at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6200872/. The whole study is in English.
Photo source: pixabay.com (author: VSRao)